XCOPRI
Pronunciation: sen-oe-BAM-ayt (ex-KOE-pree)


What it isSodium channel blocker and GABA-A positive modulator; focal seizures.
Why this oneProduces seizure freedom in a substantial minority of refractory patients, which few adjuncts achieve.
What limits itVery slow titration is mandatory to avoid DRESS. QT shortening; it induces CYP3A4 and inhibits CYP2C19.
Animated chart of estimated U.S. prescriptions per year, Antiseizure meds (1869–2026). Cenobamate enters in 2020 (estimated).
Principal riskDRESS unless titration is slow
Legacy pregnancy categoryNot assigned — PLLR-era drug
Defining liabilityDRESS with rapid titration, profound sedation/interactions and QT shortening.
Read the full label on DailyMed ↗
NO BOXED WARNINGS
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Partial-onset seizures | Adult | 12.5 mg QD | 200 mg QD | 400 mg QD |
Titration Increase per schedule no faster than every 2 weeks; above 200 mg, +50 mg QD every 2 weeks
Renal Mild-severe (CLcr <90): use caution, consider dose reduction; not recommended in ESRD/dialysis (CLcr <15)
Hepatic Mild-moderate (Child-Pugh A-B): max 200 mg QD; severe (C): not recommended
Available strengths
Pregnancy No adequate human data; enroll in NAAED Antiepileptic Drug Pregnancy Registry
Lactation No human milk data; present in rat milk
| Strength | #/mo | generic $/mo | brand $/mo | CostPlus | |
|---|---|---|---|---|---|
| 12.5 mg | tab | 30 qd | — | not offered | |
| 25 mg | tab | 30 qd | — | $1,196.46 | not offered |
| 50 mg | tab | 30 qd | — | $1,195.70 | not offered |
| 100 mg | tab | 30 qd | — | $1,196.15 | not offered |
| 150 mg | tab | 30 qd | — | $1,195.89 | not offered |
| 200 mg | tab | 30 qd | — | $1,196.32 | not offered |
Generic entry2032 est.
Open Cenobamate in the interactive console ↗
Open Cenobamate in the interactive console ↗